← All Sponsors
SPONSOR

Dizal Pharmaceuticals

Total Trials
3
Recruiting
3
Phases
Phase 1, Phase 2, Phase 1
Conditions studied: Advanced Solid TumorsDiffuse Large B-Cell LymphomaLymphoma, Non-Hodgkin
NCT07328217 Phase 1, Phase 2
Recruiting

A Phase 1/2 Study of GW5282 in Participants With Advanced Solid Tumors

Advanced Solid Tumors
China View Trial →
NCT07059650 Phase 1, Phase 2
Recruiting

DZD8586 Combination Therapy in Patients With Diffuse Large B-cell Lymphoma (TAI-SHAN12)

Diffuse Large B-Cell Lymphoma
China View Trial →
NCT05824585 Phase 1
Recruiting

DZD8586 in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Lymphoma, Non-Hodgkin
United States, Australia View Trial →